Growth factor delivery for tissue engineering

Pharmaceutical Research

Volumn 17, Issue 5, 2000, Pages 497-504

  Babensee, Julia E ^a   McIntire, Larry V ^b   Mikos, Antonios G ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Rice University   (United States)

Author keywords

Bone; Controlled release; Growth factors; Liver; Nerve; Tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER; GROWTH FACTOR; HYDROXYACID; OSTEOGENIC PROTEIN 1; POLYMER; TRANSFORMING GROWTH FACTOR BETA1;

BIOENGINEERING; DEVICE; DRUG DELIVERY SYSTEM; IMPLANT; LIVER; MUSCLE TISSUE; NERVOUS TISSUE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOMEDICAL ENGINEERING; GROWTH SUBSTANCES; HUMANS; TISSUE TRANSPLANTATION;

EID: 0034122571     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007502828372     Document Type: Review

References (90)

1. 1. I. A. McKay and I. Leigh. Growth Factors: A Practical Approach IRL Press, Oxford, 1993.
2. 2. G. Ahrendt, D. E. Chickering, and J. P. Ranieri. Angiogenic growth factors: A review for tissue engineering. Tissue Eng. 4:117-130(1998).
3. 3. J. M. Schmitt, K. Hwang, S. R. Winn, and J. O. Hollinger. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J. Orthop. Res. 17:269-278 (1999).
4. 4. D. F. Bowen-Pope, T. W. Malpass, D. M. Foster, and R. Ross. Platelet-derived growth factor in vivo: Levels, activity, and rate of clearance. Blood 64:458-469 (1984).
5. 5. R. Langer and M. Moses. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J. Cell. Biochem. 45:340-345 (1991).
6. 6. S. P. Baldwin and W. M. Saltzman. Materials for protein delivery in tissue engineering. Adv. Drug Del. Rev. 33:71-86 (1998).
7. 7. Y. H. Bae and S. W. Kim. Drug Delivery. In C. W. Patrick, A. G. Mikos, and L. V. McIntire. (eds.). Frontiers In Tissue Engineering. Elsevier Science Inc., Oxford, UK, 1998, pp. 261-277.
8. 8. H. Lo, S. Kadiyala, S. E. Guggino, and K. W. Leong. Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J. Biomed. Mater. Res. 30:475-484 (1996).
9. 9. K. Whang, D. C. Tsai, E. K. Nam, M. Aitken, S. M. Sprague, P. K. Patel, and K. E. Healy. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J. Biomed. Mater. Res. 42:491-499 (1998).
10. 10. N. Fournier and C. J. Doillon. Biological molecule-impregnated polyester: An in vivo angiogenesis study. Biomaterials 17:1659-665 (1996).
11. 11. Y. Tabata, A. Nagano, and Y. Ikada. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 5: 127-138 (1999).
12. 12. K. Whang, T. K. Goldstick, and K. E. Healy. Controlled release of macromolecules from bioabsorbable emulsion freeze-dried scaffolds: In vitro protein release. J. Controlled Rel. (in press)
13. 13. D. J. Mooney, P. M. Kaufmann, K. Sano, S. P. Schwendeman, K. Majahod, B. Schloo, J. P. Vacanti, and R. Langer. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnol. Bioeng. 50:422-429 (1996).
14. 14. J. E. Babensee, J. M. Anderson, L. V. McIntire, and A. G. Mikos. Host response to tissue engineered devices. Adv. Drug Del. Rev. 33:111-139 (1998).
15. 15. M. S. Schoichet, F. T. Gentile, and S. R. Winn. The use of polymers in the treatment of neurological disorders A discussion emphasizing encapsulated cell therapy. TRIP 3:374-380 (1995).
16. 16. I. Ito, G. Chen, and Y. Imanishi. Artificial juxtacrine stimulation for tissue engineering. J. Biomater. Sci. Polym. Ed. 9:879-890 (1998).
17. 17. S. T. Carbonetto, M. M. Gruver, and D. C. Turner. Nervefiber growth on defined hydrogel substrates. Science 216:897-899 (1982).
18. 18. P. R. Kuhl and L. G. Griffith-Cima. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nature Med. 2:1022-1027 (1996).
19. 19. J. M. Anderson. Biocompatibility of tissue-engineered implants. In C. W. Patrick, A. G. Mikos, and L. V. McIntire (eds.). Frontiers In Tissue Engineering. Elsevier Science Inc., Oxford, UK. 1998, pp. 152-165.
20. 20. J. A. Hubbell. Biomaterials in tissue engineering. Biotechnologv 13:565-576 (1995).
21. 21. M. E. Nimni. Polypeptide growth factors: Targeted delivery systems. Biomaterials 18:1201-1225 (1997).
22. 22. K. Whang, K. E. Healy, D. R. Elenz, E. K. Nam, D. C. Tsai, C. H. Thomas, G. W. Nuber, F. H. Glorieux, R. Travers, and S. M. Sprague. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng. 5:35-51 (1999).
23. 23. J. N. Beresford. Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. 240:270-280 (1989).
24. 24. J. H. Brekke. A rationale for delivery of osteoinductive proteins. Tissue Eng. 2:97-114 (1996).
25. 25. E. A. Wang, D. I. Israel, S. Kelly, and D. P. Luxenberg. Bone morphogenetic protein-2 causes commitment and differentiation of C3H10T1/2 and 3T3 cells. Growth Factors 9:57-71 (1993).
26. 26. I. Asahina, T. K. Sampath, and P. V. Hauschka. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp. Cell Res. 222:38-47 (1996).
27. 27. A. Rezania, C. H. Thomas, A. B. Branger, C. M. Waters, and K. E. Healy. Detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J. Biomed. Mater. Res. 37:9-19 (1997).
28. 28. A. I. Caplan. Cartilage begets bone versus endochondral myelopoiesis. Clin. Orthop. 261:257-267 (1990).
29. 29. H. Uludag, D. D'Augusta, R. Palmer, G. Timony, and J. Wozney. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 46:193-202 (1999).
30. 30. H. Bentz, J. A. Schroeder, and T. D. Estridge. Improved local delivery of TGF-β2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. J. Biomed. Mater. Res. 39: 539-548 (1998).
31. 31. Y. Tabata, A. Nagano, M. Muniruzzaman, and Y. Ikada. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials 19:1781-1789 (1998).
32. 32. Y. Tabata, K. Yamada, S. Miyamoto, I. Nagata, H. Kikuchi, I. Aoyama, M. Tamura, and Y. Ikada. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19:807-815 (1998).
33. 33. L. Hong, Y. Tabata, M. Yamamoto, S. Miyamoto, K. Yamada, N. Hashimoto, and Y. Ikada. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J. Biomater. Sci. Polym. Ed. 9:1001-1014 (1998).
34. 34. J. O. Hollinger, J. M. Schmitt, D. C. Buck, R. Shannon, S-P. Joh, H. D. Zegzula, and J. Wozney. Recombinant human bone morpholgenetic protein-2 and collagen for bone regeneration. J. Biomed. Mater. Res. (Appl. Biomater.). 43:356-364 (1998).
35. 35. D. L. Wheeler, D. L. Chamberland, J. M. Schmitt, D. C. Buck, J. H. Brekke, J. O. Hollinger, S-P. Joh, and K-W. Suh. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model. J. Biomed. Mater. Res. 43:365-373 (1998).
36. 36. Y. J. Park, Y. Ku, C. P. Chung, and S. J. Lee. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. J. Contr. Rel. 51:201-211 (1998).
37. 37. J. H. Brekke and J. M. Toth. Principles of tissue engineering applied to programmable osteogenesis. J. Biomed. Mater. Res. (Appl. Biomater.). 43:380-398 (1998).
38. 38. G. Zellin and A. Linde. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J. Biomed. Mater. Res. 35:181-190 (1997).
39. 39. S. C. Lee, M. Shea, M. A. Battle, K. Kozitza, E. Ron, T. Turek, R. G. Schaub, and W. C. Hayes. Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. J. Biomed. Mater. Rex. 28:1149-1156 (1994).
40. 40. R. Kenley, L. Marden, T. Turek, L. Jin, E. Ron, and J. O. Hollinger. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-s (rhBMP-2). J. Biomed. Mater. Res. 28:1139-1147 (1994).
41. 41. K. Ohura, C. Hamanishi, S. Tanaka, and N. Matsuda. Healing of segmental bone defects in rats induced by a β-TCP-MCPM cement combined with rhBMP-2. J. Biomed. Mater. Res. 44: 168-175 (1999).
42. 42. D. M. Arm, A. F. Tencer, S. D. Bain, and D. Celino. Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth. Biomaterials 17:703-709 (1996).
43. 43. J. M. Schmitt, D. Buck, S. Bennett, W. Skalla, C. Christoforou, D. Buechter, E. Gruskin, and J. O. Hollinger. Assessment of an experimental bone wax polymer plus TGF-β1 implanted into calvarial defects. J. Biomed. Mater. Res. 41:584-592 (1998).
44. 44. S. R. Winn, J. M. Schmitt, D. Buck, Y. Hu, D. Grainger, and J. O. Hollinger. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. J. Biomed. Mater. Res. 45:414-421 (1999).
45. 45. S. A. Tan and P. Aebischer. The problems of delivering neuroactive molecules to the CNS. Ciba Foundation Symposium 196:211-239 (1996).
46. 46. M. F. Haller and W. M. Saltzman. Nerve growth factor delivery systems. J. Controlled Release 53:1-6 (1998).
47. 47. P. A. Starr, T. Wichmann, C. van Home, and R. A. Bakay. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant. 8:37-45 (1999).
48. 48. P. A. Trsco. Encapsulated cells for sustained neurotransmitter delivery to the central nervous system. J. Controlled Release 28:253-258 (1994).
49. 49. J. Sautter, J. L. Tseng, D. Braguglia, P. Aebischer, C. Spenger, R. W. Seiler, H. R. Widmer, and A. D. Zurn. Implants of polymerencapsulated genetically modified cells releasing glial cell line derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol. 149:230-236 (1998).
50. 50. M. H. Tuszynski and N. Weidner. Grafts of genetically modified Schwann cells to the spinal cord: Survival, axon growth and myelination. Cell Transplant 7:185-194 (1998).
51. 51. J. H. Kordower, S. R. Winn, Y -T. Liu, E. J. Mufson, J. R. Sladek, J. P. Hammang, E. E. Baetge, and D. F. Emerich. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. USA 91:10898-10902 (1994).
52. 52. D. F. Emerich, J. P. Mammang, E. E. Baetge, and S. R. Winn. Implantation of polymer-encapsulated nerve growth factor-secreting fibroblasts attenuates the behavioral and neoropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 130:141-150 (1994).
53. 53. M. D. Lidner, S. R. Winn, E. E. Baetge, J. P. Hammang, F. T. Gentile, E. Doherty, P. E. McDermott, B. Frydel, D. Ullman, T. Schallert, and D. F. Emerich. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and Parkinsonian symptoms. Exp. Neurol. 132:62-76 (1995).
54. 54. P. Aebischer, M. Schluep, N. Deglon, J -M. Joseph, L. Hirt, B. Heyd, M. Goddard, J. P. Hammang, A. D. Zurn, A. C. Kato, F. Regli, and E. E. Baetge. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med. 2:696-699 (1996).
55. 55. S. R. Winn, J. P. Hammang, D. F. Emerich, A. Lee, R. D. Palmiter, and E. E. Baetge. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. USA 91:2324-2328 (1994).
56. 56. R. Vejsada, J. L. Tseng, R. M. Lindsay, A. Acheson, P. Aebischer, and A. C. Kato. Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons. Neurosci. 84:129-139 (1998).
57. 57. P. Aebischer, A. N. Salessiotis, and S. R. Winn. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J. Neurosci. Res. 23:282-289 (1989).
58. 58. V. Guenard, N. Kleitman, T. K. Morrissey, R. P. Bunge, and P. Aebischer. Syngeneic Schwann cells derived from adult nerves seeded in semipermeable guidance channels enhance peripheral nerve regeneration. J. Neurosci. 12:3310-3320 (1992).
59. 59. X. M. Xu, V. Guenard, N. Kleitman, P. Aebischer, and M. B. Bunge. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp. Neurol. 134:261-272 (1995).
60. 60. W. F. A. Den Dunnen, I. Stokroos, E. H. Blaauw, A. Holwerda, A. J. Pennings, P. H. Robinson, and J. M. Schakenraad. Light microscopic and electron-microscopic evaluation of short-term nerve regeneration using a biodegradable poly(DL-lactide-ε-caprolactone) nerve guides. J. Biomed. Mater. Res. 31:105-115 (1996).
61. 61. M. S. Widmer, P. K. Gupta, L. Lu, R. K. Meszlenyi, G. R. D. Evans, K. Brandt, T. Savel, A. Gurlek, C. W. Patrick, and A. G. Mikos. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials 19:1945-1955 (1998).
62. 62. F. Langone, S. Lora, F. M. Veronese, P. Caliceti, P. P. Parnigotto, F. Valenti, and G. Palma. Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis. Biomaterials 16:347-353 (1995).
63. 63. M. H. Spilker, I. V. Yannas, H. P. Hsu, T. V. Norregaard, S. K. Kostyk, and M. Spector. The effects of collagen-based implants on early healing of the adult rat spinal cord. Tissue Eng. 3:309-317 (1997).
64. 64. X. J. Tong, K. Hirai, H. Shimada, Y. Mizutani, T. Izumi, N. Toda, and P. Yu. Sciatic nerve regeneration navigated by lamininfibronectin double coated biodegradable collagen grafts in rats. Brain Res. 663:155-162 (1994).
65. 65. B. R. Sickel, D. Jones, K. J. Hekimian, K. K. Wong, D. P. Chakalis, and P. D. Costas. Hyaluronic acid through a new injectable nerve guide delivery system enhances peripheral nerve regeneration in the rat. J. Neurosci. Res. 40:318-324 (1995).
66. 66. E. M. Powell, M. R. Sobarzo, and W. M. Saltzman. Controlled release of nerve growth factor from a polymeric implant. Brain Res. 515:309-311 (1990).
67. 67. X. Cao and M. S. Schoichel. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 20:329-339 (1999).
68. 68. C. E. Krewson and W. M. Saltzman. Transport and elimination of recombinant human NGF during long-term delivery to the brain. Brain Res. 727:169-181 (1996).
69. 69. C. E. Krewson, R. Dause, M. Mak, and W. M. Saltzman. Stabilization of nerve growth factor in controlled release polymers and in tissue. J. Biomater. Sci. Polym. Ed. 8:103-117 (1996).
70. 70. N. Belcheva, K. Woodrow-Mumford, M. J. Mahoney, and W. M. Saltzman. Synthesis and biological activity of polyethylene glycol-mouse nerve growth factor conjugate. Bioconjug. Chem. 10:932-937 (1999).
71. 71. D. J. Mooney, S. Park, P. M. Kaufmann, K. Sano, K. McNamara, J. P. Vacanti, and R. Langer. Biodegradable sponges forhepatocyle transplantation. J. Biomed. Mater. Res. 29:959-965 (1995).
72. 72. D. J. Mooney, K. Sano, P. M. Kaufmann, K. Majahod, B. Schloo, J. P. Vacanti, and R. Langer. Long-term engraftment of heplocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 37:413-420 (1997).
73. 73. N. Fausto. Growth factors in liver development, regeneration, and carcinogenesis. Prog. Growth Factor Res. 3:219-234 (1991).
74. 74. T. H. Kim, H. M. Lee, H. Utsonomiya, P. Ma, R. Langer, E. V. Schmidt, and J. P. Vacanti. Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering. Transplant. Proc. 29:858-860 (1997).
75. 75. C. Ricordi, P. E. Lacy, M. P. Gallery, P. W. Park, and M. W. Flye. Tropic factors from pancreatic islets ion combined hepatocyteislet allografts enhance hepatocellular survival. Surgery 105: 218-223 (1989).
76. 76. P. M. Kaufmann, K. Sano, S. Ukama, and J. P. Vacanti. Heterotopic hepatocyte transplantation using three-dimensional polymers. Evaluation of the stimulatory effects by portacaval shunt or islet cell co-transplantation. Transplant. Proc. 26:3343-3345 (1994).
77. 77. Y. M. Elcin, V. Dixit, K. Lewin, and G. Gitnick. Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach. Artificial Organs 23:146-152 (1999).
78. 78. J. O. Hollinger and K. Leong. Poly(α-hydroxy acids): Carriers for bone morphogenetic proteins. Biomaterials 17:187-194 (1996).
79. 79. M. Isobe, Y. Yamazaki, M. Mori, K. Ishihara, N. Nakabashi, and T. Amagasa. The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat. J. Biomed. Mater. Res. 45:36-41 (1999).
80. 80. Y. Kuboki, H. Takita, D. Kobayashi, E. Tsurugea, M. Inoue, M. Murata, N. Nagai, Y. Dohi, and H. Ohgushi. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J. Biomed. Mater. Res. 39:190-199 (1998).
81. 81. B. D. Boyan, C. H. Lohmann, A. Somers, G. G. Niederauer, J. M. Wozney, D. D. Dean, D. L. Carnes, and Z. Schwartz. Potential of porous poly-D, L-lactide-co-glycolide particles as a carrier for recombinant bone morphogenetic protein-2 during osteoinduction in vivo. J. Biomed. Mater. Res. 46:51-59 (1999).
82. 82. E. M. Santos, S. Radin, B. J. Shenker, I. M. Shapiro, and P. Ducheyne. Si-Ca-P xerogels and bone morphogenetic protein act synergistically on rat stromal marrow cell differentitation in vitro. J. Biomed. Mater. Res. 41:87-94 (1998).
83. 83. P. J. Boyne, R. E. Marx, M. Kevins, G. Triplett, E. Lazaro, L. C. Lilly, M. Alder, and P. Nummikoski. A feasibility study evaluation rhBMP-2/absorbable collagen sponge for maxillary sinus augmentation. Int. J. Periodont. Restor. Dent. 17:11-25 (1997).
84. 84. M Yamamoto, Y. Tabata, and Y. Ikada. Ectopic bone formation by biodegradable hydrogels incorporating morphogenetic protein. J. Biomater. Sci. Polym. Ed. 9:439-458 (1998).
85. 85. M. L. Renier and D. H. Kohn. Development and characterization of a biodegradable polyphosphate. J. Biomed. Mater. Res. 34:95-104 (1997).
86. 86. L. Lu, G. N. Stamatas, and A. G. Mikos. Controlled release of transforming growth factor-β1 from biodegradable polymer microparticles. J. Biomed. Mater. Res. (in press).
87. 87. S. J. Peter, L. Lu, D. J. Kim, G. N. Stamatas, M. J. Miller, M. J. Yaszemski, and A. G. Mikos. Effects of transforming growth factor-β1 released from biodegradable polymer microparticles on marrow stromal cells cultured on poly(propylene fumarate) substrates. J. Biomed. Mater. Res. (in press).
88. 88. W. R. Gombotz, S. C. Sankey, L. S. Bouchard, J. Ranchalis, and P. Puolakkainen. Controlled release of TGF-β from a biodegradable matrix for bone regeneration. J. Biomater. Sci. Polym. Ed. 5:49-63 (1993).
89. 89. S. B. Nicoll, S. Radin, E. M. Santos, R. S. Tuan, and P. Ducheyne. In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier. Biomaterials 18: 853-859 (1997).
90. 90. H. D. Kim and R. F. Valentini. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-β delivered from controlled-release polymer rods. Biomaterials 18:1175-1184 (1997).